Back
Abits Group, Inc. Vs. Novo Nordisk A/S Industry Stock Comparison
Sell
29
ABTS
Abits Group, Inc.
Last Price:
$6.06
Seasonality Move:
-4.69%
Sell
32
NONOF
Novo Nordisk A/S
Last Price:
$50.52
Seasonality Move:
2.46%
Sell
29
Abits Group, Inc. (ABTS)
is a Sell
Is Abits Group, Inc. a Buy, Sell or Hold?
-
The current Abits Group, Inc. [ABTS] share price is $5.78. The Score for ABTS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
ABTS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Novo Nordisk A/S (NONOF)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NONOF] share price is $49.02. The Score for NONOF is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ABTS Stock Price Chart
What is Abits Group, Inc.'s stock price today?
-
The Abits Group, Inc. share price today is $5.78Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABTS is experiencing selling pressure, which indicates risk of future bearish movement.
NONOF Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $49.02Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.
ABTS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 45.77 | Sell |
| Chaikin Money Flow: | -1943 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.71 - 6.31) | Sell |
| Bollinger Bands (100): | (4.05 - 7.75) | Sell |
NONOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.67 | Sell |
| Relative Strength Index (14 RSI): | 51.31 | Buy |
| Chaikin Money Flow: | -16522 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
ABTS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.06 | Sell |
| 20-day SMA: | 5.97 | Sell |
| 50-day SMA: | 6.79 | Sell |
| 200-day SMA: | 4.79 | Buy |
| 8-day EMA: | 6.02 | Sell |
| 20-day EMA: | 6.09 | Sell |
| 50-day EMA: | 6.27 | Sell |
| 200-day EMA: | 5.91 | Sell |
NONOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.93 | Buy |
| 20-day SMA: | 47.64 | Buy |
| 50-day SMA: | 51.31 | Sell |
| 200-day SMA: | 61.95 | Sell |
| 8-day EMA: | 47.95 | Buy |
| 20-day EMA: | 48.15 | Buy |
| 50-day EMA: | 50.49 | Sell |
| 200-day EMA: | 63.88 | Sell |
Abits Group, Inc. Earnings Growth & ABTS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk A/S Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
Abits Group, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||